These results were consistent with previous studies that HNRNPA2B1 promotes tumor progress through regulating EMT in colorectal cancer (CRC) (42), breast cancer (48), and pancreatic cancer (49). The gene discussed is HNRNPA2B1; the disease is neoplasm.